ORGANIC
LETTERS
2004
Vol. 6, No. 18
3059-3061
Concise Asymmetric Synthesis of
(5R)-6-Hydroxy-3,8-dioxabicyclo[3.2.1]octane
Derivatives
Chong-Feng Pan, Zu-Hui Zhang, Gao-Jun Sun, and Zhi-Yong Wang*
Department of Chemistry, UniVersity of Science and Technology of China, Hefei,
Anhui, 230026, P. R. China
Received May 28, 2004
ABSTRACT
A concise method to asymmetrically synthesize 6-hydroxy-3,8-dioxabicyclo[3.2.1]octane (HDBO) derivatives was devised.
3,8-Dioxabicyclo[3.2.1]octane (DBO) exists in natural prod-
ucts and their analogues, notably, in the bicyclic analogues
of zoapatanol. Zoapatanol, isolated from the leaves of the
zoapatle plant (Montanoa tomentosa), has attracted much
attention for its antifertility activity and structure features
(Figure 1, a).1 Several of its bicyclic analogues have been
synthesized, and they possess an even higher antifertility
activity (one example is shown in Figure 1, b).2 6-Hydroxy-
3,8-dioxabicyclo[3.2.1]octane (HDBO) also exists in bio-
active compounds such as some conformationally restricted
nucleoside analogues.3
(IPG). The corresponding product was obtained with a
relatively high total yield and a high enatiomeric excess (ee).
The retrosynthetic analysis is shown in Scheme 1. The
C(2)-O(3) bond in the target molecule i is disconnected to
give the intermediate ii. ii is a typical product of iodo-
cyclization reaction5 and can be accessed from iii. Retrosyn-
thetic ketal formation of iii leads to iv. The C(1)-C(2) bond
in iv is disconnected, which gives allylic substrate v and IPG
vi. The retrosynthetic analysis makes it clear that, in the
actual synthetic procedure, iodocyclization of iii not only
Traditional synthetic methods took at least seven steps to
construct DBO or HDBO,3,4 which usually had a low yield.
In this paper, we propose a new, concise method to
asymmetrically synthesize HDBO derivatives in only four
steps, starting from (R)-2,3-O-isopropylideneglyceraldehydes
(1) Levine, S. D.; Adams, R. E.; Chen, R.; Cotter, M. L.; Hirsch, A. F.;
Kane, V. V.; Kanojia, R. M.; Shaw, C.; Wachter, M. P.; Chin, E.;
Huettemann, R.; Ostrowski, P.; Mateos, J. L.; Noriega, L.; Guzman, A.;
Mijarez, A.; Tovar, L. J. Am. Chem. Soc. 1979, 101, 3404.
(2) (a) Kanojia, R. M.; Chin, E.; Smith, C.; Chen, R.; Rowand, D.;
Levine, S. D.; Wachter, M. P.; Adams, R. E.; Hahn, D. J. Med. Chem.
1985, 28, 796. (b) Walba, D. M.; Stoudt, G. S. J. Org. Chem. 1983, 48,
5404. (c) Takayanagi, H.; Shirasaka, T.; Morita, Y. Synthesis 1991, 722.
(3) Kaemo, L.; Wengel, J. J. Org. Chem. 2001, 66, 5498.
(4) (a) Chen, R.; Hajos, Z. G. J. Org. Chem. 1984, 49, 4743. (b) Wachter,
M. P.: Hajos, Z. G.; Adams, R. E.; Werblood, H. M. J. Org. Chem. 1985,
50, 2216.
Figure 1. Zoapatanol (a) and one of its bicyclic analogues (b).
10.1021/ol049008u CCC: $27.50 © 2004 American Chemical Society
Published on Web 08/11/2004